Skip to content
buyWeak

Snehal Patel bought $92k of GLSI

CEO and CFO at Greenwich LifeSciences, Inc.. 4,300 shares at an average of $21.36, traded Dec 31, 2025, filed Jan 5, 2026.

Conviction score
38
Value
$92k
4,300 shares
Holdings after
5,599,402
+0% from before
From 52-week low
+168%
low $7.85, close $21.01
From 52-week high
-15%
high $24.78, as of Dec 31, 2025

Score components

  • Role
    CEO
    +25
  • Trade size
    $92k at market
    +9
  • Relative to holdings
    Under 1% of holdings (0.1%)
    -5
  • Price context
    15% below the 52-week high
    +4
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    6 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +27.3%, 3m +3.9%, 6m -3.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

GLSIOct 12, 2026 · close 17.77
Since filing Jan 5, 2026: -16.2%SPY +14.0% · excess -30.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-26-000229, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 31, 2025POpen-market purchase
Common Stock
+4,300$21.36$92k5,599,402Jan 5, 2026

Related signals

Other insiders at Greenwich LifeSciences, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
33Weak
GLSIbuy
Greenwich LifeSciences, Inc.
Snehal Patel
CEO and CFO
$30k
2,200 shares
+0%
28Weak
GLSIbuy
Greenwich LifeSciences, Inc.
Snehal Patel
CEO and CFO
$20k
1,500 shares
+0%
29Weak
GLSIbuy
Greenwich LifeSciences, Inc.
Snehal Patel
CEO and CFO
$47k
3,600 shares
+0%
32Weak
GLSIbuy
Greenwich LifeSciences, Inc.
Snehal Patel
CEO and CFO
$54k
1,800 shares
+0%
34Weak
GLSIbuy
Greenwich LifeSciences, Inc.
Snehal Patel
CEO and CFO
$80k
2,900 shares
+0%
33Weak
GLSIbuy
Greenwich LifeSciences, Inc.
Snehal Patel
CEO and CFO
$63k
2,900 shares
+0%
32Weak
GLSIbuy
Greenwich LifeSciences, Inc.
Snehal Patel
CEO and CFO
$52k
4,100 shares
+0%
49Moderate
GLSIbuy
Greenwich LifeSciences, Inc.
Snehal Patel
CEO and CFO
$39k
4,600 shares
+0%
52Moderate
GLSIbuy
Greenwich LifeSciences, Inc.
Snehal Patel
CEO and CFO
$89k
10,600 shares
+0%
38Weak
GLSIbuy
Greenwich LifeSciences, Inc.
Snehal Patel
CEO and CFO
$21k
2,300 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Snehal Patel bought $92k of GLSI | InsiderTell